Business description
Kyowa Kirin Co Ltd is a drug manufacturing company focusing on biological drugs. Its activities focus on four categories: nephrology, oncology, immunology and allergy, and central nervous system. The company has two business sectors: pharmaceuticals and biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products and others.
Management board & Supervisory board
| CEO |
| Masashi Miyamoto |
| Management board |
| Yutaka Osawa, Takeyoshi Yamashita |
| Supervisory board |
| Yuko Haga, Takeshi Minakata, Masashi Miyamoto, Akira Morita, Rumiko Nakata, Yutaka Osawa, Takashi Oyamada, Yoshihisa Suzuki, Takeyoshi Yamashita |
Company data
| Name: |
Kyowa Hakko Kirin Co., Ltd. |
| Address: |
1-9-2, Otemachi,Chiyoda-ku, Tokyo 100-0004 |
| Phone: |
+81-3-5205-7200 |
| Fax: |
+81-3-5205-7182 |
| E-mail: |
-
|
| Internet: |
https://www.kyowakirin.com/index.html |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
Satoko Yoshida |
| IR phone: |
+81 3 5205 7206 |
| IR Fax: |
- |
| IR e-mail: |
-
|
